GeneDx Holdings (WGS) Capital Expenditures Growth (1y) (2021 - 2026)
GeneDx Holdings (WGS) Capital Expenditures Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 50.00% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 3.87% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | -3.27% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | -72.44% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | -33.33% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 1.48% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | -10.56% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 18.75% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 0.92% |
| 10 | GeneDx Holdings | 1.65 Bn | 1.48 Bn | 68.21 Mn | 169.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 169.23% |
| Dec 31, 2025 | -5,474.36% |
| Sep 30, 2025 | 359.69% |
| Jun 30, 2025 | 6,029.31% |
| Mar 31, 2025 | 395.94% |
| Dec 31, 2024 | 114.36% |
| Sep 30, 2024 | 155.60% |
| Jun 30, 2024 | 5,900.00% |
| Mar 31, 2024 | -4.11% |
| Dec 31, 2023 | 83.28% |
| Sep 30, 2023 | -79.74% |
| Jun 30, 2023 | -100.07% |
| Mar 31, 2023 | -66.47% |
| Dec 31, 2022 | -1,243.31% |
| Sep 30, 2022 | 3,433.96% |
| Jun 30, 2022 | 168.91% |
| Mar 31, 2022 | -33.59% |
| Dec 31, 2021 | -97.62% |